Hematology

Hematology

Imatinib Mesylate (STI571) Demonstrates Promising Results in Treating Multiple Myeloma

Researchers at the University of Coimbra in Spain have made a significant breakthrough in the treatment of multiple myeloma, a type of blood cancer, by discovering that Imatinib Mesylate (STI571) can suppress the proliferation of tumor cells in vitro. According to a recent study published in the British Journal of

Hematology

Rituximab Does Not Significantly Increase Survival in Older Patients with Diffuse Large B-Cell Lymphoma

A study presented at the 45th Annual Meeting of the American Society of Hematology found that adding rituximab to the standard chemotherapy regimen for lymphoma patients with diffuse large B-cell lymphoma did not significantly increase survival in older patients. The research team, led by Thomas Habermann, MD, of the Eastern